Walgreens Boots Alliance Inc (WBA) : Highfields Capital Management Lp scooped up 2,792,350 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 4,434,362 shares of Walgreens Boots Alliance Inc which is valued at $369,471,042.Walgreens Boots Alliance Inc makes up approximately 3.53% of Highfields Capital Management Lp’s portfolio.
Other Hedge Funds, Including , Cipher Capital Lp reduced its stake in WBA by selling 23,325 shares or 89.83% in the most recent quarter. The Hedge Fund company now holds 2,640 shares of WBA which is valued at $219,965. Walgreens Boots Alliance Inc makes up approx 0.01% of Cipher Capital Lp’s portfolio.Rand Wealth reduced its stake in WBA by selling 4,995 shares or 4.93% in the most recent quarter. The Hedge Fund company now holds 96,409 shares of WBA which is valued at $7,763,817. Walgreens Boots Alliance Inc makes up approx 1.02% of Rand Wealth’s portfolio.Mizuho Trust Banking Ltd. boosted its stake in WBA in the latest quarter, The investment management firm added 60,191 additional shares and now holds a total of 1,453,171 shares of Walgreens Boots Alliance Inc which is valued at $115,672,412. Walgreens Boots Alliance Inc makes up approx 0.34% of Mizuho Trust Banking Ltd.’s portfolio.Capital City Trust Cofl boosted its stake in WBA in the latest quarter, The investment management firm added 352 additional shares and now holds a total of 2,752 shares of Walgreens Boots Alliance Inc which is valued at $223,875. Walgreens Boots Alliance Inc makes up approx 0.09% of Capital City Trust Cofl’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $81.04 and hit $81.71 on the upside on Thursday, eventually ending the session at $81.54, with a gain of 1.03% or 0.83 points. The heightened volatility saw the trading volume jump to 32,96,108 shares. Company has a market cap of $88,252 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.